ArticlePDF Available

Innovation in Healthcare Delivery Systems: A Conceptual Framework

Authors:

Abstract and Figures

The healthcare industry has experienced a proliferation of innovations aimed at enhancing life expectancy, quality of life, diagnostic and treatment options, as well as the efficiency and cost effectiveness of the healthcare system. Information technology has played a vital role in the innovation of healthcare systems. Despite the surge in innovation, theoretical research on the art and science of healthcare innovation has been limited. One of the driving forces in research is a conceptual framework that provides researchers with the foundation upon which their studies are built. This paper begins with a definition of healthcare innovation and an understanding of how innovation occurs in healthcare. A conceptual framework is then developed which articulates the intervening variables that drive innovation in healthcare. Based on the proposed definition of healthcare innovation, the dimensions of healthcare innovation, the process of healthcare innovation and the conceptual framework, this paper opens the door for researchers to address several questions regarding innovation in healthcare. If the concept of healthcare innovation can be clarified, then it may become easier for health policymakers and practitioners to evaluate, adopt and procure services in ways that realistically recognize, encourage and give priority to truly valuable healthcare innovations. Lastly, this paper presents 10 research questions that are pertinent to the field of healthcare innovation. It is believed that the answers to these and other such questions will hold the key to future advances in healthcare innovation research. Key words: Healthcare innovation, innovation process
Content may be subject to copyright.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
1
Innovation in Healthcare Delivery Systems:
A Conceptual Framework
Vincent K. Omachonu*
Department of Industrial Engineering
University of Miami
Coral Gables, Florida 33124 USA
E-mail: vomachonu@miami.edu
*Corresponding Author
and
Norman G. Einspruch
Department of Electrical and Computer Engineering
University of Miami
Coral Gables, Florida 33124 USA
E-mail: neinspruch@miami.edu
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
2
Innovation in Healthcare Delivery Systems: A Conceptual Framework
Vincent K. Omachonu and Norman G. Einspruch
ABSTRACT
The healthcare industry has experienced a proliferation of innovations aimed at enhancing life
expectancy, quality of life, diagnostic and treatment options, as well as the efficiency and cost
effectiveness of the healthcare system. Information technology has played a vital role in the
innovation of healthcare systems. Despite the surge in innovation, theoretical research on the art
and science of healthcare innovation has been limited. One of the driving forces in research is a
conceptual framework that provides researchers with the foundation upon which their studies are
built. This paper begins with a definition of healthcare innovation and an understanding of how
innovation occurs in healthcare. A conceptual framework is then developed which articulates the
intervening variables that drive innovation in healthcare. Based on the proposed definition of
healthcare innovation, the dimensions of healthcare innovation, the process of healthcare
innovation and the conceptual framework, this paper opens the door for researchers to address
several questions regarding innovation in healthcare. If the concept of healthcare innovation can
be clarified, then it may become easier for health policymakers and practitioners to evaluate,
adopt and procure services in ways that realistically recognize, encourage and give priority to
truly valuable healthcare innovations. Lastly, this paper presents 10 research questions that are
pertinent to the field of healthcare innovation. It is believed that the answers to these and other
such questions will hold the key to future advances in healthcare innovation research.
Key words: Healthcare innovation, innovation process
Introduction
Innovation in healthcare continues to be a driving force in the quest to balance cost containment
and health care quality. Innovation is considered to be a critical component of business
productivity and competitive survival [Zaltman, et al., 1973]. Technological innovations present
vast opportunities for 1) product innovation the introduction of new types of goods and services
for the external market and 2) process innovation enhancement of internal production processes
for goods and services [Perri 6, 1993]. Product innovations are essential to the life of any
organization since they provide the most obvious means for generating incremental revenues
[Johne, 1999]. Similarly, process innovation is concerned with improving internal capabilities
[Johne and Davies, 2000; Johne, 1999] and safeguarding and improving quality [Johne, 1999].
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
3
In 2005, industryweek.com did a study about the effects of innovation on a company and they
found that, ―overall revenue growth (78%), customer satisfaction (76%), growth in revenue from
new products or services (74%), increased productivity (71%), and earnings/profit margins
(68%)‖ were a result of the impact of innovation efforts. [Jusko, 2008].
Medical science has advanced exponentially during the last half a century. Yet, the paper system
has stymied the ability of care givers to access the information vital to the delivery of care.
Patient information is routinely held in static paper storage systems and managed with a silo
mentality. Of the $600 billion spent on lab tests each year in the U.S., 70 percent of that money
pays for paperwork, says Shanker S. Sastry, Engineering Dean at the University of California,
Berkeley, and Director Emeritus of the Center for Information Technology Research in the
Interest of Society (CITRIS). Paperwork is prone to costly errors. Sastry argues that huge savings
can be realized by more and better use of electronic recordkeeping, employing software that can
detect mistakes and issue prompts [Grose, 2008]. When healthcare providers have to rely on
paper records, the sharing of information and the delivery of care become challenging and often
impossible. Without full and secure access to patient records, healthcare services providers would
give up the vital insight provided by the patients’ health history. The healthcare industry sits on
the hinge of a future in which physicians can instantly share imaging and test results with
colleagues in the same building or across the country or continent. Patients should be able to have
immediate access to their own records and be able to transmit or carry it from one healthcare
provider to another. Innovation has become a critical capability of all healthcare organizations
[Lansisalmi, et al., 2006]. In addition, new digital information, nanotechnology, semiconductor
products, and genetic engineering are revolutionizing health care, making old assumptions invalid
and creating unanticipated prospects for innovation and improvement of existing processes
[Govindarajan, 2007]. The last century has produced a proliferation of innovations in the health
care industry aimed at enhancing life expectancy, quality of life, disgnostic and treatment
options, as well as the efficiency and cost effectiveness of the healthcare system [Varkey, Horne
and Bennet, 2006]. These include, but are not limited to, innovations in the process of care
delivery [Varkey and Athyal, 2005], medications, and surgical interventions [Varkey, Horne and
Bennet, 2006]. In a study by Fuchs and Sox (Fuchs and Sox, 2001), medications (e.g.,
angiotensin-converting enzyme inhibitors, statins, proton pump inhibitors, antidepressants),
diagnostic modalities (e.g., magnetic resonance imaging, computerized tomography scanning,
mammography), and procedures (e.g., balloon angioplasty, coronary artery bypass graft, cataract
extraction) made the list of top 10 medical innovations.
Definitions of Innovation
Innovation can be defined as the intentional introduction and application within a role, group, or
organization, of ideas, processes, products or procedures, new to the relevant unit of adoption,
designed to significantly benefit the individual, the group, or wider society‖ [West, 1990]. This
definition is largely accepted among researchers in the field [Anderson, et al., 2004], as it
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
4
captures the three most important characteristics of innovation: (a) novelty, (b) an application
component and (c) an intended benefit [Lansisalmi, et al., 2006]. In line with this definition,
innovation in healthcare organizations are typically new services, new ways of working and/or
new technologies [Lansisalmi, et al., 2006]. From the patient’s point of view, the intended
benefits are either improved health or reduced suffering due to illness [Faulkner and Kent,
2001].The Advisory Committee on Measuring Innovation in the 21st Century Economy (2007)
defines innovation as ―the design, invention, development and/or implementation of new or
altered products, services, processes, systems, organizational structures, or business models for
the purpose of creating new value for customers and financial returns for the firm.‖ [Varkey, et
al., 2008] define innovation as the successful implementation of a novel idea in a way that creates
compelling value for some or all of the stakeholders. Innovation can be categorized by its impact
on stakeholders as nondisruptive or disruptive. Nondisruptive innovations [Moore, 2004], also
referred to as incremental [Hamel, 2000; Harvard Business Essentials, 2003], evolutionary,
[Govindarajan, 2007], linear, [Hamel, 2000], or sustaining, [VHA Health Foundation, 2006],
improve on something that already exists but in a way that allows expanded opportunities to be
met, or existing problems to be solved, [Harvard Business Essentials, 2003]. Christenson, et al.,
(2004) propose a narrower focus of impacting a company: ―anything that creates new resources,
processes, or values or improves a company's existing resources, processes, or values.‖ What is
important in defining innovation is the recognition that something new and hopefully better will
emerge.
Disruptive innovations, also called radical, [Harvard Business Essentials, 2003; Hage and
Hollingsworth, 2000], revolutionary, [Govindarajan, 2006; Harvard Business Essentials, 2003],
transformational, or nonlinear, [Hamel, 2000], refer to innovations that disorder old systems,
create new players and new markets while marginalizing old ones, and deliver dramatic value to
stakeholders who successfully implement and adapt to the innovation. The Minute Clinic, with
limited service diagnostic and treatment offerings in major retail outlets, is an example of a
nondisruptive structural innovation, [Varkey, 2008]. The clinics are easily accessible, efficient,
and cost-effective and have generated significant interest in consumer markets across the United
States. However, they have not replaced existing medical facilities.
West and Farr [1990] define organizational innovation as the intentional introduction and
application (within a group or organization) of ideas, processes, products or procedures, new to
the relevant unit of adoption, designed to significantly benefit the individual, the group,
organization or wider society. There have been several attempts to classify innovation into
categories.
Innovation is the implementation of a new or significantly improved product (good or service), or
process, a new marketing method, or a new organizational method in business practices,
workplace organization or external relations [UNESCO Institute for Statistics, 2005]. UNESCO
makes the distinction among the four types of innovation as follows:
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
5
Product innovation: introduction of a good or service that is new or significantly
improved with respect to its characteristics or intended uses. This includes
significant improvements in technical specifications, components and materials,
incorporated software, user friendliness or other functional characteristics.
Process innovation: implementation of a new or significantly improved
production or delivery method. This includes significant changes in techniques,
equipment and/or software. The customer does not usually pay directly for
process, but the process is required to deliver a product or service and to manage
the relationship with the various stakeholders.
Marketing innovation: implementation of a new marketing method involving
significant changes in product design or packaging, product placement, product
promotion or pricing.
Organizational innovation: implementation of a new organizational method in
the firm’s business practices, workplace organization or external relations.
Innovations in health care are related to product, process, or structure [Varkey, et al., 2008]. The
product is what the customer pays for and typically consists of goods or services (for example,
clinical procedure innovations). Process innovation entails innovations in the production or
delivery method. According to Varkey, et al., the customer does not usually pay directly for
process, but process is required in order to deliver a product or service. A process innovation,
therefore, would be a novel change to the act of producing or delivering the product that allows
for a significant increase in the value delivered to one or more stakeholders. Structural innovation
usually affects the internal and external infrastructure, and creates new business models.
Healthcare innovation can be defined as the introduction of a new concept, idea, service,
process, or product aimed at improving treatment, diagnosis, education, outreach, prevention
and research, and with the long term goals of improving quality, safety, outcomes, efficiency and
costs.
Information technology remains a key driver of innovation in healthcare. According to Gupta
(2008),
―while hospitals and other care providers have long been quick to adopt
breakthrough technology in medical devices, procedures and treatments, far less
attention has focused on innovations in networking and communications. This is
partly because of concerns about breaches in security and patient privacy, and
because healthcare until recently was a service always performed locally and in
person.‖
With the dramatic improvements in network security and the ability to transmit images and data
globally, the opportunity to revolutionize the healthcare industry has never been greater. There
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
6
are four major ways in which Information Technology (IT) will revolutionize health care, [Gupta,
2008]:
More offshore services: There is a tremendous growth in the outsourcing of diagnostic services
particularly imaging, such as X-rays and mammograms and consultations by specialists.
Telemedicine has been used by doctors in the U.S. and other countries to provide care to patients
in hard-to-reach and underserved locations. Gupta notes that the future of telemedicine lies in its
use as a way of distributing work loads and lowering costs. An example is Teleradiology, a
process in which X-rays are taken at one location and then transmitted to doctors at another site.
The factors driving the growth in teleradiology include a significant shortage of radiologists,
aging populations and more of imaging in trauma situations, which in turn has fueled the need for
round-the-clock radiological services in emergency departments [Gupta, 2008].
Integration of health information systems: Much of today’s health information systems were
designed to function as silos, with their own rules and formats. They often inhibit the opportunity
for information to be globally integrated and readily available. In some cases, a patient’s chart in
one hospital cannot be read by another hospital. According to Gupta, not only are different
languages and measures sometimes used, but conflicts between encryption and other software can
make it impossible for systems to exchange data electronically. The goal should be to create
medical records that can travel with the patient.
Drug safety monitoring on a global scale: The need for an international database on drug safety
has steady increased, especially as more people travel across the globe. There are programs
aimed at addressing the gaps that currently exist, however, more work is required. Medwatch, (an
initiative of the U.S. Food and Drug Administration) investigates and reports on adverse drug
reactions and other safety issues involving medical products. Gupta, 2008 notes that no agency
routinely collects and shares information between countries.
More high quality information to doctors and patients: Websites such as WebMD have
become a source of information for patients and doctors. These sites receive contributions of
medical materials from doctors and scientists, and are enhanced by the automated search tools.
Many such sites draw materials from on-line text books and medical journals.
Healthcare Innovation and the Challenges of Labor
The universal shortage of nurses and other key practitioners further advances the argument in
favor more innovation in healthcare. This situation has been exacerbated by the projected
increase in the retirement of current staff in the next 10 years [Pirkanmaa Hospital District, 2004;
Warne & McAndrew, 2002].
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
7
Tracking Technologies
Automatic-tracking software programs were introduced more than a decade ago to help hospitals
prevent infant abductions. Now, institutions are putting electronic tags on all sorts of things, from
EKG monitors and ventilators so they can be readily be located in an emergency, to surgical
sponges so they do not get sewn up inside a patient. According to Landro, 2008, some hospitals
have begun tagging arriving patients to help cut waiting times in emergency rooms. The growing
use of tracking technology has privacy experts warning that hospitals mast take steps to protect
any personal data from being inadvertently released. About 10% of U.S. hospitals use some kind
of radio frequency identification, or RFID, tags, the most common tracking technology,
according to ECRI Institute, a nonprofit consulting group. Active RFID tags were the subject of a
study by the Journal of the American Medical Association, JAMA, that warned of possible
interference with medical devices.
Other Examples of Healthcare Innovation
1. An electronic Personal Health Record solution (ePHR) to enable consumers to record and
selectively share healthcare information about themselves and their loved ones in a secure
manner.
2. An electronic Clinician Health Record solution (eCHR) to enable physicians and other
healthcare providers to securely access healthcare information collated from any number
of trusted sources relating to an individual patient in a structured and easily accessible
way.
3. A healthcare informatics platform to enable all healthcare data to be stored and accessed
via the ePHR and eCHR solutions. The platform is based on industry-standard
technologies and data models.
4. The use of robots in rehabilitation therapy for victims of stroke. Robots being built by a
team at MIT are able to help deliver therapy with the promise of reducing elbow and
shoulder impairments in stroke victims [Riezenman, 2008].
5. High definition television signals used in cameras (known as videoscopes) by surgeons to
snake through patients’ bodies to search for stomach tumors, perform colonoscopies, or
assist in removing diseased gallbladders.
6. The da Vinci Surgical System allows physicians to perform minimally invasive
procedures most commonly in the treatment of urological and gynecological conditions.
Seated at a console, a physician can view the surgical area through a tiny camera that
reveals magnified 3-D images. The controls at the console allow the physician to move
robotic ―hands‖ with precision, eliminating the natural tremor of human hands. The
physician can perform complex surgery using 1- to 2-centimeter incisions, and patients
generally recover in less than 48 hours.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
8
7. The CyberKnife Stereotactic Radiosurgery System is used by physicians to deliver high
doses of radiation with great accuracy, which allows incisionless surgery for previously
inoperable tumors. It minimizes radiation exposure to healthy tissue and lets physicians
operate on multiple tumors in several locations. Patients spend between 30 minutes and
an hour and a half on the operating table (some cases may require up to five sessions), and
there is no recovery time.
8. The Elekta Synergy Cone Beam CT system for image guided radiation therapy provides a
3-D view of the patient and can detect very small shifts in position that can be corrected
before treatment. The system incorporates a linear digital accelerator with a built-in CT
scanner that, like the CyberKnife, allows physicians to deliver a high dose of radiation
with great accuracy. In the past, it was difficult to target the tumor because it could not be
seen. It is primarily used to treat prostate cancer and cancers of the head and neck.
9. Ablation therapy has transformed what 20 years ago was a risky, invasive open-heart
surgery for treatment of abnormal heart rhythms to a procedure that takes a matter of
hours and has a 95 percent success rate. The therapy can fix an irregular heartbeat
permanently, possibly replacing defibrillators and pacemakers. Small wires can be routed
through the femoral vein and placed into the heart so the electrical conduction system of
the heart can be evaluated and the exact location of the problem can be identified using 3-
D mapping. Then radiofrequency energy is transmitted to the problem area and destroys
selected heart muscle cells in a very small area to stop the area from conducting the extra
impulses that caused rapid heartbeats.
10. Intel Corp. is taking its next step in building a business in health care by introducing
technology to help homebound patients with chronic medical problems such as diabetes,
hypertension and heart disease [Clark, 2008]. Intel’s offerings include a simplified
computer and software that are designed to help elderly people and other patients monitor
and manage their conditions at home. It connects to medical devices such as scales,
blood-pressure monitors and glucose readers, recording information that can be shared
with health professionals over the Internet.
Health care is rich in evidence-based innovations, yet even when such innovations are
implemented successfully in one location, they often disseminate slowlyif at all. Diffusion of
innovations is a major challenge in all industries including health care [Berwick, 2003]. The
International Council of Nurses (ICN) has developed a website designed to showcase innovations
in nursing. The ICN Innovations Database is a web based resource designed to facilitate the
dissemination of nursing innovations globally.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
9
Key Stakeholders of the Healthcare Innovation Process
The process of innovation is both complex and multi-dimensional regardless of the industry in
which it is being applied. Innovation in the healthcare industry has its own unique challenges.
Any attempt to understand the process of innovation in healthcare must begin with an in-depth
analysis of its challenges. There are five key stakeholders in the innovation process, and each has
its unique and deliberate needs, wants and expectations as follows:
Stake Holders
Needs, Wants & Expectations
Physicians and Other Care Givers
Improved clinical outcomes, improved diagnosis and
treatment
Patients
Improved patients’ experience, improved
physiological well-being, reduced waiting time,
reduced delay
Organizations
Enhanced efficiency of internal operations, cost
containment, increased productivity and quality and
outcomes improvement
Innovator Companies
Profitability, improved outcomes
Regulatory Agencies
Reduced risks and improved patient safety
Several researchers have suggested that it is difficult to change the behavior of clinicians [Greco
and Eisenberg, 1993], current medical practices, and healthcare organizations [Shortell, Bennett,
and Byck, 1998; Shortell et al., 2001]. The adoption of healthcare innovations is often regulated
by laws, making changes more laborious [Faulkner and Kent, 2001]. In healthcare, typical
starting points of an innovation process may lead to death, disability, or permanent discomfort
[Lansisalmi, et al., 2006]. This, together with the clinicians’ tendencies to protect their individual
autonomy and reputation, can promote a culture of blame and secrecy that inhibits organizational
learning and the generation of innovations [Huntington, Gilliam and Rosen, 2000]. Furthermore,
new practices in patient care are traditionally scrutinized thoroughly in their early development
phase so that potentially harmful innovations are not adopted [Faulkner and Kent, 2001]. Any
attempt at modeling the process of health care innovation must take into account all of the five
key stakeholders.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
10
Healthcare Innovation
Quality Costs Efficiency Outcomes
T R E A T M E N T
D I A G N O S I S
P R E V E N T I O N
E D U C A T I O N
R E S E A R C H
Information
Technology
Healthcare
Practitioners
and Providers
How the
Patient is
Seen
How the
Patient is
Heard
The Patient
O U T R E A R C H
Safety
How the
Patient’s
needs are met
Figure 1: A Conceptual Framework for Innovation in Healthcare
As Figure 1 shows, healthcare organizations serve six distinct purposes treatment, diagnosis,
prevention, education, research and outreach. In serving these purposes, healthcare organizations
must effectively manage quality, costs, safety, efficiency and outcomes. At the very core of
healthcare innovation are the needs of patients and the healthcare practitioners and providers who
deliver care. Quite often, healthcare organizations arrive at innovation by relying on new or
existing information technology. When successful, healthcare innovation focuses on three areas
the most a) how the patient is seen, b) how the patient is heard, and c) how the patient’s needs
are met.
Role of Research and Development
In industry, there are two closely related processes by which new products/services and new
forms of old products/services are created through technological innovation - two types of
research, basic and applied. Basic research is directed toward a generalized goal (e.g., genetic
research in a pharmaceutical laboratory). Applied research directs the results of basic research
toward the needs of a specific industry and results in the development of new or modified
products or processes. In addition to carrying out basic and applied research and developing
models, R&D staff may evaluate the efficiency and cost of the product [Britannica Concise
Encyclopedia, 2006].
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
11
There is a fundamental distinction between R&D in the physical, engineering, and life sciences
and R&D in the social sciences and humanities. Important areas of research and development in
the physical, engineering, and life sciences fields include biotechnology, nanotechnology,
pharmaceutical, chemical and materials science, electronics, aerospace, and automotive.
Important fields of research and development in the social sciences and humanities include
economics, sociology, anthropology, and psychology [Bureau of Labor and Statistics, 2008].
These distinctions are critical to the process of innovation in healthcare [Omachonu and
Einspruch, 2009]. Many of the innovations in healthcare rely on the cognitive sciences due to the
special considerations that must be made to accommodate the patients’ experience. Clinicians
are, by virtue of their training, familiar with experimental research methods driven by the fields
of basic and life sciences. When certain healthcare innovations seek to create a new structure or
organizational practice, they force the clinician to venture outside the familiar into the cognitive
sciences. Sometimes, the cognitive sciences fail to produce the types of quantitative answers to
research questions that clinicians want and expect. This creates credibility problems in the eyes of
many medical practitioners [Pope, 1995; Pope and Mays, 2000].
Cognitive Science
Cognitive science may be broadly defined as the multidisciplinary study of mind and behavior
[Lugar, 1994]. It draws on multiple empirical disciplines, including psychology, psychiatry,
philosophy, neuroscience, linguistics, anthropology, computer science, sociology and biology.
Perception is the ability to take in information via the senses and process it in some way. Vision
and hearing are two dominant senses that allow us to perceive the environment.
The Process of Innovation
Despite the fact that much has been written about the process of innovation; however, there is
very little information concerning the process of innovation in health care. Although the process
of innovation typically is not linear, the majority of innovations go through the process of
problem identification and idea generation, idea evaluation, development, first use,
commercialization, and diffusion [Varkey et al., 2008].
The Process of Healthcare Innovation
In order to fully understand the process of innovation in healthcare, it is critical to answer the
question, what is the catalyst for healthcare innovation? Another way to ask the question is to ask
a) if innovation chases needs or b) if needs chase innovation? In the first case, new or existing
technology searches for a problem to solve, whereas in the second case, new or existing problems
chase after solutions in the form of innovation. Stated differently, it comes down to solutions
looking for problems to solve versus problems looking for solutions to adopt. In either case,
technology plays a pivotal role in facilitating the process. Figure 1 below is an example of how
the process works.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
12
Figure 2: The Process of Healthcare Innovation
Many of the innovations in healthcare have been initiated by the healthcare stakeholders
(patients, patient advocacy groups, healthcare organizations, physicians, other healthcare
professionals, etc.) In some cases, the need for change is forced upon the healthcare organizations
by the government in an effort to mitigate healthcare concerns and challenges. Once the need is
identified, the next challenge lies in determining whether the need can be met internally or by a
healthcare innovation company. If the innovation originates from within the healthcare
organization, it is tested, modified and adopted. If it does not originate from within the healthcare
organization, the need is instead met by a healthcare technology company that develops, tests and
markets the technology to healthcare organizations. In certain cases, a healthcare innovation
company takes what might be an imperfect attempt at innovation from a healthcare organization
and refines it into a better product, and then markets it to healthcare organizations. It is important
to understand the internal process of innovation within a healthcare organization such as a
hospital, nursing home, home health, or managed care company. These organizations typically do
not have the luxury of a huge research & development department, and so must rely on the raw
talent and creativity of internal staff and work teams. As figure 2 illustrates, a managed care
company may rely upon the feedback from its sales and marketing field staff; a hospital might
rely upon feedback from patients, physicians and staff; and both groups may rely on information
regarding competitors in order to commence the search for improvement. In some cases, the
limitations in the resources available to the healthcare organizations force them to partner with a
healthcare innovation company to create a product that meets their needs.
Omachonu and Einspruch (2009) presented a Service Organizations Innovation Process model
(Figure 3) as shown below. The implications for healthcare organizations are quite significant.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
13
There are at least three stages to the maturing of a services industry. First, it creates a service that
the market needs. Then it improves the service to meet what the market wants and demands.
[Beckwith (1997)]. According to Beckwith, this is usually the stage where most services
companies assume they have reached the goal. But some rare companies move beyond stage two,
they innovate and devise services that would never even occur to a customer to ask for. They
create ―the possible service.‖ This kind of service can not be created by asking the question ―what
do my customers want?‖ but rather ―what would they love?‖ This underscores the idea that
services innovation is not always driven by customer input. In order to obtain answers to the
question ―what would they love?‖, healthcare organizations can examine the interactions between
services and technology. The answers tend to lie in one of the four quadrants depicted in Figure 3
below. Stage III innovation can be supported by applying a new technology to new service
(quadrant 1), new technology to an existing service (quadrant 2), existing technology to existing
service (quadrant 3), and existing technology to a new service (quadrant 4).
Create a Service
or Product that
the market needs
Pilot-Test &
Improve Service
to meet what the
market wants
and demands
Stage I Stage II Stage III
Innovate and
devise Services
that would never
even occur to a
customer to ask for
Existing New
Services
Technology
NewExisting
1
23
4
Services
R&D
Humanities Social
Sciences
Convene
Formal or
Informal
Team
Customer
Feedback
Sales Reps
Feedback
Intelligence
from
Competitor
For Products:
Partnership with
External
companies
Figure 3: Service Organizations Innovation Model
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
14
The Dimensions of Innovation in Healthcare
There are two principal dimensions of healthcare innovation environmental and operational
dimensions. These dimensions motivate or affect the introduction of innovation in healthcare
organizations. The operational dimension includes the improvement of clinical outcomes,
efficiency, effectiveness, aging population, nursing shortage, patient satisfaction, profitability,
patient safety, improved quality and cost containment. The environmental dimension includes
physician acceptance, organizational culture, regulatory acceptance, and partnerships and
collaborations. Figure 4 below shows the factors.
Figure 4: Environmental and Operational Dimensions of Healthcare Innovation
The dimensions of healthcare innovation can be divided into two bands the outer band which
represents the environmental dimensions and the inner band which represents the operational
dimensions. The Environmental Dimensions (ED) include organizational leadership,
organizational culture, regulatory acceptance, physician acceptance, complexity of innovation,
and partnerships and collaboration. Similarly, the Operational Dimensions (OD) of healthcare
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
15
innovation include patient satisfaction, profitability, effectiveness, efficiency, patient safety,
aging population, productivity, cost containment, labor shortage, clinical outcomes, and quality.
As organizations strive for ways to control health care spending, ameliorate labor shortages,
address the growing needs of an aging population, and respond to a more informed, sophisticated,
and demanding consumer base [Elaine, 2002], the need for innovation has become critical to
enhance quality of care [Varkey, Horne and Bennet, 2006].
Diffusion of Health Care Innovation
There are seven critical success factors for the dissemination of health care innovation, Berwick
(2003).
Formal mechanisms to find sound innovations that should be disseminated
Find and support innovators
Invest in early adopters
Make early adopter activity observable
Trust and enable reinvention
Create slack (including resources) for change
Lead by example
The best of innovations may not be successful if the market or environment is not ready for
adoption [Varkey, et al., 2008]. Berwick notes that in health care, invention is hard, but
dissemination is even harder.
Questions for further research and discussions
There are several questions that must be addressed in trying to measure, manage, and deploy
healthcare innovation. They include the following:
I. How would innovation affect the key stakeholders of a healthcare organization?
II. What are the implications of a particular healthcare innovation on treatment, diagnosis,
prevention, education, research and outreach?
III. Since every organization is different in terms of its culture, leadership, people, and
resources, what steps are taken by individual healthcare organizations in adapting an
existing technology for their purposes?
IV. What are the principal catalysts for healthcare innovations the patients, physicians,
costs, safety, quality, profitability, productivity, etc.?
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
16
V. How do physicians, nurses and other clinical professionals learn about the latest
innovations in their fields? Is it done through conferences, medical journals, from
colleagues, other professions, etc? What are the barriers to disseminating healthcare
innovation? What is the average time it takes for disseminating innovation? What is the
cost of delays in disseminating healthcare innovation?
VI. To what degree do regulatory compliance issues drive the necessity for healthcare
innovation?
VII. How much does healthcare innovation depend on information technology? In which of
the following sectors (treatment, diagnosis, research, outreach, education, and prevention)
is the application of information technology more prevalent, and why?
VIII. Consider the four quadrants presented as part of Figure 3. What is the nature of the
interaction between new and existing technology and new and existing services? Are
there differences that are driven by the type of healthcare facility or organization?
IX. With regards to innovations in healthcare, how much ―cross pollination‖ occurs within the
various professions represented in healthcare? For example, do nurses come up with
innovative ideas that mainly support nursing practice, or do nurses get help from other
disciplines?
X. How should the healthcare industry address the issues of maintainability, sustainability
and usability with regards to healthcare innovation?
According to Lehoux, et. al. (2008) innovation designers rarely tap into the knowledge generated
by health services researchers while health services researchers often fail to provide key insights
about the comparative value of emerging innovations, such as their significance within the
broader universe of desirable health care interventions. As a result, after decades of research,
there is an acute lack of knowledge about ways to promote the design of more valuable
innovations [Lehoux, 2006]. Part of the solution is to develop a new collaborative policy-oriented
research agenda that can bridge design processes, and health care needs and priorities. This idea is
beginning to be recognized by academics and high-level policy-makers around the world [Reiss,
2003; HM Treasury, 2004].
Many of the issues discussed in this paper can become the basis for empirical research inquiries.
Healthcare innovation can become a formal discipline that appeals to a multidisciplinary research
audience. The conceptual framework presented in this paper should open a dialogue regarding the
interaction among the many factors driving innovation in healthcare. The dimensions of
innovation identify the environmental and operational factors that influence healthcare
innovation. The innovation process presented in this paper depicts both the thought and practical
steps followed by many healthcare organizations in pursuing the benefits of innovation. The
information presented in this paper may assist policy makers in understanding the many
components of healthcare innovation, thereby influencing the quality of decision-making.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
17
About the Authors
Vincent Omachonu, Ph.D., P.E. is an Associate Professor of Industrial Engineering at the at the
University of Miami. He received his Ph.D. in Industrial Engineering from the Polytechnic
Institute of New York, Brooklyn. He has two masters degrees - one in Operations Research from
Columbia University, New York, and the other in Industrial Engineering from the University of
Miami, Florida. His B.S. degree is also in Industrial Engineering from the University of Miami.
Dr. Omachonu was one of the early contributors to the field of health care quality management.
His seminal book titled Total Quality and Productivity Management in Health Care
Organizations received the Institute of Industrial Engineers Joint Publishers Book-of-the-Year
Award in 1993. Dr. Omachonu is a Master Black Belt in Six Sigma. Dr. Omachonu’s other books
include Principles of Total Quality (co- authored with J. Ross) and Healthcare Performance
Improvement. He has supervised the implementation of the quality management process in
several organizations including hospitals, managed care companies, home health care
organizations, Federally qualified community health centers, non-profit organizations and
educational institutions. He has successfully conducted industrial engineering efficiency and
patient flow studies (based on EHR system) in community health organizations. Dr. Omachonu
has served as the evaluator for federally and State funded projects (SAMHSA, OMH, Department
of Health, Ryan White, etc.) He has been featured twice on CNN Business (discussing quality in
healthcare organizations).
Norman G. Einspruch received the Ph. D. degree in Applied Mathematics from Brown
University. He was employed by Texas Instruments Incorporated for eighteen years in a variety
of technical/managerial positions, including Director of the Central Research Laboratories.
During the last thirty-two years at the University of Miami, he has served as Dean of the College
of Engineering and as Chairman of the Department of Industrial Engineering; he is Senior Fellow
in Science and Technology, Professor of Electrical and Computer Engineering and Professor of
Industrial Engineering. His current research area, in which he has published extensively, relates
to characterizing the similarities and differences between the Goods Sector and the Services
Sector of the economy, with special emphasis on the role of technology and technology
management. He is a Life Fellow of the Institute of Electrical and Electronics Engineers, a
Fellow of the American Physical Society, a Fellow of the Acoustical Society of America, and a
Fellow of the American Association for the Advancement of Science. neinspruch@miami.edu
P.O. Box 248581, Coral Gables, FL 33124-8581, (305) 284-3812.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
18
References
Anderson, N., C. De Dreu, and B.A. Nijstad. 2004. The Routinization of Innovation
Research: A Constructively Critical View of the State-of-the-Science. Journal of
Organizational Behavior, 25: 147-173.
Berwick, D.M. 2003. ―Disseminating Innovations in Health Care,‖ JAMA. 289: 1969-1975.
Clark, D., 2008. ―Intel Takes Step Into Home Health Care.‖ The Wall Street Journal, p. B3.
Christenson, C. M., S.D. Anthony, and E.A. Roth, 2004. Seeing What's Next: Using the
Theories of Innovation to Predict Industry Change. Boston: Harvard Business School Press;
vol. 293.
Elaine, D. 2002. The Seeds of Innovation: Cultivating the Synergy That Fosters New Ideas.
1st ed. New York, NY: AMACOM/American Management Association.
Faulkner, A. and J. Kent. 2001. Innovation and Regulation in Human Implant Technologies:
Developing Comparative Approaches. Social Science and Medicine, vol. 53: 895-913.
Fuchs, V. R. and H.C. Sox, Jr. 2001. Physicians’ Views of the Relative Importance of Thirty
Medical Innovations. Health Affairs (Millwood) vol. 20: 30-42.
Govindarajan, V. 2007. The Importance of Strategic Innovation.
http:/www.vijaygovindarajan.com/2006/03/the_importance_of_strategic_in.htm.
Greco, P. and J.M. Eisenberg. 1993. Changing Physicians’ Practices. New England Journal of
Medicine, 329: 1271-1273.
Grose, T. K. 2008. Life Support Systems. Prism Magazine.org, pp. 35-39.
Gupta, A., 2008. ―Prescription for Change.‖ The Wall Street Journal, October 20, p. R6.
Hage, J. and R.A. Hollingsworth. 2000. A Strategy for Analysis of Idea Innovation Networks
and Institutions. Organizational Studies, vol. 21: 971-1004.
Hamel, G. 2000. Leading the Revolution. Boston, MA: Harvard Business School Press.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
19
Harvard Business Essentials. 2003. Managing Creativity and Innovation. Boston, MA:
Harvard Business School Press.
HM Treasury, 2004. Government of the United Kingdom. Science and Innovation Investment
Framework 20042014. London: The Stationery Office, 2004
Huntington, J. S. Gilliam, and R. Rosen. 2000. Organizational Development for Clinical
Governance, British Medical Journal, vol. 16: 679-682.
Landro, L. 2008. ―The Hospital Is Watching You.‖ The Wall Street Journal, p. D4.
Lansisalmi, H., M. Kivimaki, P. Aalto, and R. Ruoranen. 2006. Innovation in Healthcare: A
Systematic Review of Recent Research. Nursing Science Quarterly, vol. 19: 66-72.
Lehoux, P., B. Williams-Jones, F. Miller, D. Urbach, and S. Tailliez. 2008. ―What leads to
better health care innovation? Arguments for an integrated policy-oriented research agenda.‖
Journal of Health Services Research & policy, (4)13: 251-254.
Lehoux P. 2006. The Problem of Health Technology. Policy Implications for Modern Health
Care Systems. New York, NY: Routledge.
Moore, G. A. 2004. Darwin and the Demon: Innovating Within Established Enterprises.
Harvard Business Review, vol. 82. P. 7.
Omachonu, V. K. and N.G. Einspruch. 2009. Innovation: Implications for Goods and
Services. Accepted for publication, International Journal of Innovation and Technology
Management.
Pirkanmaa Hospital District. 2004. Human Resource Report, Tampere, Finland: Author.
Pope, C. 1995. Qualitative Research: Reaching the Parts Other Methods Cannot Reach: An
Introduction to Qualitative Methods in Health and Health services. British Medical Journal,
vol. 311: 42-45.
Pope, C. M. and Mays, N. 2000. Qualitative Research in Health Care. London: BMJ Books.
Reiss S, Hinze I, Dominguez Lacasa V, for the European Commission. 2003. Final Report,
Efficiency of Innovation Policies in High Technology Sectors in Europe (EPOHITE).
Contract no. HPVI-CT-2001-00005. Brussels: European Commission.
Riezenman, M. J. 2008. Robots in Rehab. The Institute, p. 6.
The Innovation Journal: The Public Sector Innovation Journal, Volume 15(1), 2010, Article 2.
20
Shortell, S. M., C.L. Bennett, and G.R. Byck. 1998. Assessing the Impact of Continuous
Quality Improvement on Clinical Practice: What it Will Take to Accelerate Progress. Milbank
Quarterly, vol. 76:593-624.
Shortell, S. M., J.I. Zazzali, L.R. Burns, J.A. Alexander, R.R. Gillies, P.P. Budetti, et al.
2001. Implementing Evidence-Based Medicine. Medical Care, vol. 39: 62-78.
The Advisory Committee on Measuring Innovation in the 21st Century Economy 2007,
Federal Register: Vol. 72: 18627-18628
UNESCO Institute for Statistics, 2005. Oslow Manual, The Measurement of Scientific and
Technological Activities, 3rd Edition, p.34.
Varkey, P., A. Horne,and K.E. Bennet. 2008. Innovation in Health Care: A Primer. American
Journal of Medical Quality, vol. 23: 382-388.
Varkey, P. and V.P. Athyal. 2005. Service Delivery Innovations at Mayo Clinic. Minnesota
Medical. Vol. 88:39-42.
VHA Health Foundation. 2006. The Power of Innovation. VHA Research Series.
https://www.vhahf.org/portal/server.pt/gateway/PTARGS_0_504686_7648_1146_508257_43
/http%3B/ContentSrv.VHA.com.
Warne, T. and S. McAndrew. 2002 The Mental Health Practitioner: An Oxymoron? Journal
of Psychiatric and Mental Health Nursing, vol. 11: 179-184.
West, M.A. 1990. The Social Psychology of Innovation in Groups. In M.A. West and J.L Farr
(Eds.), Innovation and Creativity at Work: Psychological and Organizational Strategies
Chichester, UK: Wiley, pp. 309-334.
... In earlier research, innovation is seen as a key in the struggle with the healthcare industry, with decreasing income streams, rising costs and aging populations (Varkey, Horne & Bennet, 2008). Omachonu and Einspruch (2010) see the two main dimensions that contribute to innovation in the health field, one is the environment, and the other is the operational dimension. ...
Article
Full-text available
The purpose of this paper is to conduct qualitative case study on the factors that make the company profitable. The earlier profitability study is often based on quantitative research. This paper seeks to compare the results between qualitative and quantitative research as well. The research is based on a contingency theory, which argues that the profitability of a company consists of a large group of factors. The starting point was to interview highly successful SMEs management and to find out what the manager or the studied company considered important for improving their profitability. The focus of the survey was on the profitability of management accounting systems, customer concentration, innovation and digitalization activity in the company. The results show that monitoring the financial functions is vital for the company, emphasizing budgeting and financial statement tracking regularly. Even the results show that studied health care company's perceptions of improving profitability are largely those that have emerged in previous research, the customer concentration in the industry was seen, contrary to several previous results, as a positive factor in the profitability. In addition, the systematic internal innovation of the company was a factor improving profitability.
... Globally, the health systems constantly change due to ongoing innovations and interventions that aim at increasing life expectancy, quality of life, diagnostic and treatment options, as well as ensures optimal use of resources [1]. The innovations and interventions have been mostly implemented as projects that are supported and funded by both national and international agencies. ...
Article
Full-text available
Effective project procurement management is crucial for ensuring the timely and cost-efficient acquisition of goods and services in the health sector. In Tanzania, the Medical Stores Department (MSD) plays a central role in procuring, storing and distributing medical supplies to healthcare facilities nationwide. However, procurement processes in the health sector often face challenges such as inefficiencies, delays, regulatory constraints, and financial limitations, which in return impacts service delivery and health outcomes. This study aimed at exploring the practices of project procurement management of medicines and medical supplies at the MSD in Tanzania. A qualitative cross-sectional study design employing a qualitative approach in data collection process was used to explore the practices of procurement of medicines and supplies at the MSD in Tanzania. A purposive sampling approach was used to select 17 participants dealing with procurement processes at MSD; Managers, staff from finance department, accounts, procurement, and supply chain units, as well as tender board members were included in this study. A structured interview guide was used to conduct the interviews with the selected participants. A thematic approach was used to analyse the data and findings presented as themes and sub-themes. Study findings reported that, planning procurement is the first phase taken by MSD, whereby annual procurement plans, tender documents, and specifications are made. The MSD conducts procurement by advertising a tender electronically for about 14–21 days, then opens the tender and forms an evaluation team for the bids and negotiation. Then it prepares letters to inform bidders of the outcomes. In-charge of project procurement at the MSD monitors procurement by comparing delivery schedules, the quality of medicines and medical supplies (MMSs), and the price against the requirements in the contract. In the last phase, MSD closes procurement after the suppliers have been paid off and all documents are stored in the finance department. However, the participants revealed several hindrances to effective implementation of the process, including the occurrence of unforeseen circumstances, procurement taking a long time, and over-reliance of money on receipts in kind from government treasurer. Generally, despite the well-defined stages, several challenges hinder the effective implementation of procurement at MSD. Unforeseen circumstances, prolonged procurement timelines, and financial dependency on government treasury allocations create inefficiencies in the system. To enhance procurement effectiveness, MSD should adopt more flexible procurement strategies, improve process efficiency, and explore alternative funding mechanisms. Strengthening these areas will contribute to a more reliable medical supply chain, ultimately improving healthcare service delivery in Tanzania. Article Highlights Majority of MSD staff performs the project procurement management sometimes without knowing the correct definitions of it. The MSD follows all the four phases of project procurement management while procuring MMSs. The MSD lack several procurement control tools for conducting procurement of MMSs at MSD.
Preprint
Full-text available
Background Amid growing demands, workforce shortages, and rising costs, the evolving role of diagnostics –driven by technological innovation –underscores the urgent need to rethink the diagnostic process with stakeholders at the center. Knowledge on their perspectives on innovation of the diagnostic process is lacking, while it could ensure alignment with their needs and expectations. Aim To identify perspectives on innovation of the diagnostic process in general practice care. Design and setting Q-methodological study with stakeholders with different profiles but an informed opinion on the topic. Method Participants individually sorted 57 statements based on what they thought is most important for innovation of the diagnostic process in general practice care. Statements were collected from literature, media, and group meetings. Factor analyses identified different perspectives, which were subsequently holistically interpreted. Results We identified five perspectives: 1 –innovation through diagnostic transformation, 2 –innovation in communication, 3 –innovation from a doctor-centered perspective, 4 –system reform before innovation: fixing the foundation first, and 5 –ambivalence towards innovation. The perspectives differed mostly in their urge for system change and the role for technology in innovation. In some perspectives, changes in the current or future diagnostic system were identified, whereas in others not. Also, the degree to which technology was deemed as the promising way forward differed between the perspectives. Conclusion This study gives insight into prevailing perspectives of stakeholders on innovation of the diagnostic process in general practice care. Each perspective offers valuable insights, as all are essential for successful innovation of the diagnostic process.
Chapter
In today's internet economy and Web 3.0, firms are using virtual Internet portals for co-design. Product design by firms have focused predominantly on the significance of product aesthetics. Virtual co-design by firms are moving towards new product design using creative themes to focus on the aesthetics of design in association with a product function. Firms are integrating the internet for co-design, customization and the personalization of products and web portals are facilitating the personalization and customization of ideas, concepts and designs and are co-creating value for firms. Firms today have become agents of change and are adding value to professions and vocations. Today, firms acknowledge the fact that products can be designed virtually.
Preprint
Full-text available
Background With resources scarce, health and care decision-makers have to allocate resources efficiently to evaluate innovations that may likely be ready for evaluation, thus implementing and scaling up innovations that actually achieve impacts. There is a lack of understanding of guidance on how an evaluation should be pre-planned before it can proceed. Our aim was to scope published literature on the evaluability assessment frameworks on whether and how an innovation evaluation should be planned. Methods For this rapid scoping review (registration number: https://osf.io/8x2n4), we searched Ovid MEDLINE, Ovid Embase and additional resources in October 2024 to identify English language publications that reported evaluability assessment frameworks to support the planning of evaluations of innovations. We screened studies and extracted and coded data of the identified frameworks and 20 components we pre-specified, following the rapid approaches of scoping review methodology. We synthesised and presented evidence narratively and in tabular formats as required. Results We included 36 publications that reported 24 unique evaluability assessment frameworks. Only 40% (8/20) of frameworks were developed in the health and care fields. Only four frameworks (16.7%) were reported following well-acknowledged development approaches such as the Moher’s guidance development methodology. None of the 24 frameworks could result in an evaluation plan, following the assessment exercise, that users can use to carry out the expected evaluations in real-world settings. No framework was considered comprehensive in terms of the inclusion of the 20 pre-specified components, with notable omissions around health equity (not reported in any framework), and research governance (reported in 8.3%, 2/24 frameworks). Conclusions Despite the availability of several frameworks, no framework is comprehensive in using important components and instructs users to produce an actual evaluation plan following assessment exercises. It may be necessary to develop such a tool to facilitate the planning of an innovation evaluation before a formal summative evaluation. Trial registration Open Science Framework registration number https://osf.io/8x2n4
Article
Full-text available
Innovative care models have emerged as a critical strategy for addressing the growing complexity and demands of modern healthcare systems. This study evaluates the effectiveness of these models in enhancing patient outcomes and improving operational efficiency across various healthcare settings. Drawing upon a comprehensive review of peer-reviewed literature, case studies, and health system performance data, the analysis focuses on widely adopted models such as Patient-Centered Medical Homes (PCMHs), Telehealth, Accountable Care Organizations (ACOs), and Integrated Care Systems. The findings reveal that innovative care models contribute significantly to improved clinical outcomes, including reduced hospital readmissions, better chronic disease management, and enhanced patient satisfaction. Simultaneously, they promote operational gains such as cost reduction, streamlined workflows, and more effective use of healthcare resources. However, outcomes vary based on implementation strategies, workforce readiness, and technological infrastructure. The study underscores the need for evidence-based implementation, stakeholder collaboration, and ongoing evaluation to sustain long-term impact. This evaluation offers practical insights for healthcare providers, policymakers, and administrators aiming to optimize healthcare delivery through innovation.
Article
Full-text available
Amid the global rise in chronic diseases and escalating costs, functional foods have become a preventive solution, offering benefits beyond essential nutrition. However, the regulatory landscape remains complex, requiring a balance between consumer protection and industry innovation. Previous studies seldom examine how markets and regulation evolve, leaving a clear gap that this review addresses. This study aims to propose a framework focusing on the risk side (quality and safety) and benefit side (functionality) to analyze functional food regulations, and to examine the evolution of regulatory systems and their impact on industry development through a historical analysis of Japan’s functional food regulation from the 1960s. The results reveal that regulations have co-evolved with industry growth, dynamically balancing the risk and benefit sides. Milestones, such as the introduction of the Foods with Function Claims (FFC) system and the Beni-koji (red yeast rice) contamination incident in 2024, highlight adjustments in this balance. The findings suggest that the risk-/benefit-side framework provides a valuable lens for understanding the interplay between regulation and innovation in the functional food industry. This study contributes to regulatory science by offering empirical evidence from the sector and has practical implications for policymakers seeking to design frameworks that promote both innovation and consumer welfare.
Article
Full-text available
The perspective of this paper is that variation in commercially successful radical product/process innovations among science-based industrial sectors can be explored by focusing on idea innovation networks. Idea innovation networks have six arenas reflecting research basic research, applied research, product development research, production research, quality control research, and commercialization/ marketing research. The paper develops two interrelated hypotheses. The first is that the greater the diversity of competencies or knowledges that are connected with frequent and intense communication within an arena and the greater the size of the arena, and the greater the likelihood that radical innovations will emerge. The second hypothesis involves the same kind of logic: if radical solutions are to occur in more than one arena, there must be intense and frequent communication among the different arenas involving radically new ways of thinking. Radical research solutions in one arena usually involve tacit knowledge and to be effectively communicated to another arena, both tacit knowledge and codified knowledge must be communicated across arenas. However, the communication of tacit knowledge is more likely to occur when there is frequent and intense communication across arenas. In analyzing connectedness, the authors draw on the literatures about organizational innovation and organizational learning. In addition, they recognize that institutional environments shape the size of research arenas and the connectedness within and among them. The suggestion is that the more similarity there is across sectors, in patterns of research arena size and connectedness, the greater the support for a national system of innovation interpretation. Contrariwise, less similarity of network arena characteristics across sectors may mean more support for the strong role of globalization forces in affecting innovation.
Article
Full-text available
Dramatic moments in the history of industrial change have always been characterised by the successful exploitation of new ideas and the achievements of innovators. Innovation has driven economic progress, from the invention of the spinning jenny that transformed the textile industry during the 18th century, to the harnessing of electricity and the development of mass production. More recently, semi-conductors, the internet and mobile technology have revolutionised business performance and the economic potential of nations. It has been long understood that the generation, exploitation and diffusion of knowledge are fundamental to economic growth, development and the well being of nations. Central to this is the need for better measures of innovation. Innovation also affects the competitive advantage of the countries. Over time the nature and landscape of innovation have changed, and so has the need for indicators to capture those changes and provide policy makers with appropriate tools of analysis. Innovation propels economic growth. Yet the measurement of innovation, in the countries remains rudimentary. To understand better the dynamics of economic growth and, hopefully, avoid harmful policies and enact facilitative policies, we must design improved measures of innovation.Some of the aspects that will be discussed are the: Innovation and knowledge economy, Innovation policies across government, cross-country analyses of innovation.
Article
Full-text available
The concepts of goods and services innovation have been discussed extensively in the academic literature. The research has been both selective (dealing with specific attributes such as R&D, process innovation, measurement of innovation, and use of information technology) and specific (dealing with specific industries such as banking, insurance, biotechnology, nanotechnology). This paper examines the concept of innovation in the context of "goods" and "services." The comparisons made between the two sectors are based on three distinct areas — definition, process, measurement. This paper also presents a conceptual framework showing the interactions among the various variables inherent in some of the distinct areas. Previous papers have highlighted the differences in innovation between goods and services. What is missing is how the intervening variables invoked in the discussions are themselves related to one another. While this paper reinforces the conclusions reached by other studies with regard to innovation, it specifically highlights on an aggregate scale, the areas in which goods and services differ. Future research should take these distinctions into account, not as single items but collectively. It is critical to consider how these innovation variables interact with one another in the context of goods and services. Perhaps the most significant contribution of this paper is in its presentation of the framework for understanding the innovation process as it relates to the goods and services sectors.
Article
Objectives. To assess the extent to which market pressures, compensation incentives, and physician medical group culture are associated with the use of evidence-based medicine practices in physician organizations. Methods. Cross-sectional exploratory study of 56 medical groups affiliated with 15 integrated health systems from across the United States, involving 1,797 physician respondents. Larger medical groups and multispecialty groups were overrepresented compared with the United States as a whole. Data are from two sources: (1) surveys of physicians assessing the culture of the medical groups in which they work, and (2) surveys of medical directors and other managerial key informants pertaining to care management practices, compensation methods, and the management and governance of the medical groups. Physician-level data were aggregated to the group level to attain measures of group culture and then merged with the data regarding care management, incentives, and management and governance. Stepwise multiple regression was used to examine the study hypotheses. Results. As hypothesized, the number of different types of compensation incentives used (cost containment, productivity, quality) was positively associated with the comprehensiveness of care management practices. The degree of salary control (ie, market-based salary grades and ranges versus the use of bookings or fees and individual negotiation) was also positively associated with the deployment of care management practices. As hypothesized, market pressures in the form of percentages of health maintenance and preferred provider organization patients seen were generally positively associated with the use of care management practices. Organizational culture had no association except that a patient-centered culture in combination with a greater number of different types of compensation incentives used was positively associated with greater use of care management practices. Conclusions. Both compensation incentives and managed care market pressures were significantly associated with the use of evidence-based care management practices. The lack of association for culture may be due to the relatively amorphous nature of most physician organizations at this point.
Article
In this interview, international strategy guru Gary Hamel explains the thinking behind his new book, Leading the Revolution. He believes that the impetus for radical change in a business must come from the ideas and energies of the people within the company, not from consultants or external advisors. He also believes that innovation and radical change will be necessary for wealth creation in the coming years – change not only in products and processes, but change in entire business models as well. The interview includes Hamel’s guidelines for those at any level of an organization who may have ideas about new opportunities that can revolutionize the company or the industry.
Article
it is proposed that the four psychological constructs [vision, participative safety, climate for excellence, norms of and support for innovation] . . . can be used to enable prediction of innovation at work / it is further proposed that two of the constructs will relate principally to quantity of innovation and two to quality of innovation / it is argued that norms for innovation and participative safety are group process variables and are more likely to encourage quantity of attempts to introduce new ideas—the number of innovations—since they influence potential innovators by creating appropriate social reinforcement contingencies / vision and concern with quality, it is proposed, are more task or product oriented and are therefore more likely to affect the significance and quality of the innovation product—the kind of innovations (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
In this review we argue that facilitators of innovation at the individual, group, and organizational levels have been reliably identified, and that validated process models of innovation have been developed. However, a content analysis of selected research published between 1997 and 2002 suggests a routinization of innovation research, with a heavy focus on replication–extension, cross-sectional designs, and a single level of analysis. We discuss five innovative pathways for future work: Study innovation as an independent variable, across cultures, within a multi-level framework, and use meta-analysis and triangulation. To illustrate we propose a ‘distress-related innovation’ model of the relations between negatively connotated variables and innovation at the individual, group, and organizational levels of analysis. Copyright © 2004 John Wiley & Sons, Ltd.